(December 4, 2018, 2:09 PM EST) -- PHILADELPHIA — A Pennsylvania federal judge on Nov. 29 denied a motion by Bristol-Myers Squibb Corp. (BMS) to dismiss a False Claims Act, 31 U.S. Code § 3729, lawsuit alleging that it engaged in two schemes to underpay statutorily required drug rebates to Medicaid (United States of America, ex rel. Ronald J. Streck v. Bristol-Myers Squibb Company, No. 13-7547, E.D. Pa., 2018 U.S. Dist. LEXIS 203656)....